Down-regulation of DcR2 sensitizes androgen-dependent prostate cancer LNCaP cells to TRAIL-induced apoptosis. - Archive ouverte HAL Access content directly
Journal Articles Cancer Cell International Year : 2011

Down-regulation of DcR2 sensitizes androgen-dependent prostate cancer LNCaP cells to TRAIL-induced apoptosis.

(1) , (2) , , (3) , (4) , (5) , (5) , (6) , (7)
1
2
3
4
5
6
7
Marie Réveiller
  • Function : Author
  • PersonId : 853874
Jacqueline Chantepie
  • Function : Author
  • PersonId : 921380
Sadok Yakoub
  • Function : Author
  • PersonId : 921381
Catherine Deschildre
  • Function : Author
  • PersonId : 921382
Renée Grataroli
  • Function : Correspondent author
  • PersonId : 921386

Connectez-vous pour contacter l'auteur

Abstract

UNLABELLED: ABSTRACT: BACKGROUND: Dysregulation of many apoptotic related genes and androgens are critical in the development, progression, and treatment of prostate cancer. The differential sensitivity of tumour cells to TRAIL-induced apoptosis can be mediated by the modulation of surface TRAIL receptor expression related to androgen concentration. Our previous results led to the hypothesis that downregulation of TRAIL-decoy receptor DcR2 expression following androgen deprivation would leave hormone sensitive normal prostate cells vulnerable to the cell death signal generated by TRAIL via its pro-apoptotic receptors. We tested this hypothesis under pathological conditions by exploring the regulation of TRAIL-induced apoptosis related to their death and decoy receptor expression, as also to hormonal concentrations in androgen-sensitive human prostate cancer, LNCaP, cells. RESULTS: In contrast to androgen-insensitive PC3 cells, decoy (DcR2) and death (DR5) receptor protein expression was correlated with hormone concentrations and TRAIL-induced apoptosis in LNCaP cells. Silencing of androgen-sensitive DcR2 protein expression by siRNA led to a significant increase in TRAIL-mediated apoptosis related to androgen concentration in LNCaP cells. CONCLUSIONS: The data support the hypothesis that hormone modulation of DcR2 expression regulates TRAIL-induced apoptosis in LNCaP cells, giving insight into cell death induction in apoptosis-resistant hormone-sensitive tumour cells from prostate cancer. TRAIL action and DcR2 expression modulation are potentially of clinical value in advanced tumour treatment.
Fichier principal
Vignette du fichier
1475-2867-11-42.pdf (904.8 Ko) Télécharger le fichier
Vignette du fichier
1475-2867-11-42.xml (78.04 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other
Loading...

Dates and versions

inserm-00674028 , version 1 (24-02-2012)

Identifiers

Cite

David Vindrieux, Marie Réveiller, Jacqueline Chantepie, Sadok Yakoub, Catherine Deschildre, et al.. Down-regulation of DcR2 sensitizes androgen-dependent prostate cancer LNCaP cells to TRAIL-induced apoptosis.. Cancer Cell International, 2011, 11 (1), pp.42. ⟨10.1186/1475-2867-11-42⟩. ⟨inserm-00674028⟩
199 View
168 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More